1.The Korean Society for Neuro-Oncology (KSNO) Guideline for Glioblastomas: Version 2018.01
Young Zoon KIM ; Chae Yong KIM ; Jaejoon LIM ; Kyoung Su SUNG ; Jihae LEE ; Hyuk Jin OH ; Seok Gu KANG ; Shin Hyuk KANG ; Doo Sik KONG ; Sung Hwan KIM ; Se Hyuk KIM ; Se Hoon KIM ; Yu Jung KIM ; Eui Hyun KIM ; In Ah KIM ; Ho Sung KIM ; Tae Hoon ROH ; Jae Sung PARK ; Hyun Jin PARK ; Sang Woo SONG ; Seung Ho YANG ; Wan Soo YOON ; Hong In YOON ; Soon Tae LEE ; Sea Won LEE ; Youn Soo LEE ; Chan Woo WEE ; Jong Hee CHANG ; Tae Young JUNG ; Hye Lim JUNG ; Jae Ho CHO ; Seung Hong CHOI ; Hyoung Soo CHOI ; Je Beom HONG ; Do Hoon LIM ; Dong Sup CHUNG ;
Brain Tumor Research and Treatment 2019;7(1):1-9
		                        		
		                        			
		                        			BACKGROUND: There has been no practical guidelines for the management of patients with central nervous system (CNS) tumors in Korea for many years. Thus, the Korean Society for Neuro-Oncology (KSNO), a multidisciplinary academic society, started to prepare guidelines for CNS tumors from February 2018. METHODS: The Working Group was composed of 35 multidisciplinary medical experts in Korea. References were identified through searches of PubMed, MEDLINE, EMBASE, and Cochrane CENTRAL using specific and sensitive keywords as well as combinations of keywords. RESULTS: First, the maximal safe resection if feasible is recommended. After the diagnosis of a glioblastoma with neurosurgical intervention, patients aged ≤70 years with good performance should be treated by concurrent chemoradiotherapy with temozolomide followed by adjuvant temozolomide chemotherapy (Stupp's protocol) or standard brain radiotherapy alone. However, those with poor performance should be treated by hypofractionated brain radiotherapy (preferred)±concurrent or adjuvant temozolomide, temozolomide alone (Level III), or supportive treatment. Alternatively, patients aged >70 years with good performance should be treated by hypofractionated brain radiotherapy+concurrent and adjuvant temozolomide or Stupp's protocol or hypofractionated brain radiotherapy alone, while those with poor performance should be treated by hypofractionated brain radiotherapy alone or temozolomide chemotherapy if the patient has methylated MGMT gene promoter (Level III), or supportive treatment. CONCLUSION: The KSNO's guideline recommends that glioblastomas should be treated by maximal safe resection, if feasible, followed by radiotherapy and/or chemotherapy according to the individual comprehensive condition of the patient.
		                        		
		                        		
		                        		
		                        			Brain
		                        			;
		                        		
		                        			Central Nervous System
		                        			;
		                        		
		                        			Chemoradiotherapy
		                        			;
		                        		
		                        			Diagnosis
		                        			;
		                        		
		                        			Drug Therapy
		                        			;
		                        		
		                        			Glioblastoma
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Korea
		                        			;
		                        		
		                        			Radiotherapy
		                        			
		                        		
		                        	
2.The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade II Cerebral Gliomas in Adults: Version 2019.01
Young Zoon KIM ; Chae Yong KIM ; Chan Woo WEE ; Tae Hoon ROH ; Je Beom HONG ; Hyuk Jin OH ; Seok Gu KANG ; Shin Hyuk KANG ; Doo Sik KONG ; Sung Hwan KIM ; Se Hyuk KIM ; Se Hoon KIM ; Yu Jung KIM ; Eui Hyun KIM ; In Ah KIM ; Ho Sung KIM ; Jae Sung PARK ; Hyun Jin PARK ; Sang Woo SONG ; Kyoung Su SUNG ; Seung Ho YANG ; Wan Soo YOON ; Hong In YOON ; Jihae LEE ; Soon Tae LEE ; Sea Won LEE ; Youn Soo LEE ; Jaejoon LIM ; Jong Hee CHANG ; Tae Young JUNG ; Hye Lim JUNG ; Jae Ho CHO ; Seung Hong CHOI ; Hyoung Soo CHOI ; Do Hoon LIM ; Dong Sup CHUNG ;
Brain Tumor Research and Treatment 2019;7(2):74-84
		                        		
		                        			
		                        			BACKGROUND: There was no practical guideline for the management of patients with central nervous system tumor in Korea for many years. Thus, the Korean Society for Neuro-Oncology (KSNO), a multidisciplinary academic society, has developed the guideline for glioblastoma. Subsequently, the KSNO guideline for World Health Organization (WHO) grade II cerebral glioma in adults is established. METHODS: The Working Group was composed of 35 multidisciplinary medical experts in Korea. References were identified by searching PubMed, MEDLINE, EMBASE, and Cochrane CENTRAL databases using specific and sensitive keywords as well as combinations of keywords regarding diffuse astrocytoma and oligodendroglioma of brain in adults. RESULTS: Whenever radiological feature suggests lower grade glioma, the maximal safe resection if feasible is recommended globally. After molecular and histological examinations, patients with diffuse astrocytoma, isocitrate dehydrogenase (IDH)-wildtype without molecular feature of glioblastoma should be primarily treated by standard brain radiotherapy and adjuvant temozolomide chemotherapy (Level III) while those with molecular feature of glioblastoma should be treated following the protocol for glioblastomas. In terms of patients with diffuse astrocytoma, IDH-mutant and oligodendroglioma (IDH-mutant and 1p19q codeletion), standard brain radiotherapy and adjuvant PCV (procarbazine+lomustine+vincristine) combination chemotherapy should be considered primarily for the high-risk group while observation with regular follow up should be considered for the low-risk group. CONCLUSION: The KSNO's guideline recommends that WHO grade II gliomas should be treated by maximal safe resection, if feasible, followed by radiotherapy and/or chemotherapy according to molecular and histological features of tumors and clinical characteristics of patients.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Astrocytoma
		                        			;
		                        		
		                        			Brain
		                        			;
		                        		
		                        			Central Nervous System
		                        			;
		                        		
		                        			Drug Therapy
		                        			;
		                        		
		                        			Drug Therapy, Combination
		                        			;
		                        		
		                        			Follow-Up Studies
		                        			;
		                        		
		                        			Glioblastoma
		                        			;
		                        		
		                        			Glioma
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Isocitrate Dehydrogenase
		                        			;
		                        		
		                        			Korea
		                        			;
		                        		
		                        			Oligodendroglioma
		                        			;
		                        		
		                        			Radiotherapy
		                        			;
		                        		
		                        			World Health Organization
		                        			
		                        		
		                        	
3.The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade III Cerebral Gliomas in Adults: Version 2019.01
Young Zoon KIM ; Chae Yong KIM ; Jaejoon LIM ; Kyoung Su SUNG ; Jihae LEE ; Hyuk Jin OH ; Seok Gu KANG ; Shin Hyuk KANG ; Doo Sik KONG ; Sung Hwan KIM ; Se Hyuk KIM ; Se Hoon KIM ; Yu Jung KIM ; Eui Hyun KIM ; In Ah KIM ; Ho Sung KIM ; Tae Hoon ROH ; Jae Sung PARK ; Hyun Jin PARK ; Sang Woo SONG ; Seung Ho YANG ; Wan Soo YOON ; Hong In YOON ; Soon Tae LEE ; Sea Won LEE ; Youn Soo LEE ; Chan Woo WEE ; Jong Hee CHANG ; Tae Young JUNG ; Hye Lim JUNG ; Jae Ho CHO ; Seung Hong CHOI ; Hyoung Soo CHOI ; Je Beom HONG ; Do Hoon LIM ; Dong Sup CHUNG ;
Brain Tumor Research and Treatment 2019;7(2):63-73
		                        		
		                        			
		                        			BACKGROUND: There was no practical guideline for the management of patients with central nervous system tumor in Korea in the past. Thus, the Korean Society for Neuro-Oncology (KSNO), a multidisciplinary academic society, developed the guideline for glioblastoma successfully and published it in Brain Tumor Research and Treatment, the official journal of KSNO, in April 2019. Recently, the KSNO guideline for World Health Organization (WHO) grade III cerebral glioma in adults has been established. METHODS: The Working Group was composed of 35 multidisciplinary medical experts in Korea. References were identified by searches in PubMed, MEDLINE, EMBASE, and Cochrane CENTRAL databases using specific and sensitive keywords as well as combinations of keywords. Scope of the disease was confined to cerebral anaplastic astrocytoma and oligodendroglioma in adults. RESULTS: Whenever radiological feature suggests high grade glioma, maximal safe resection if feasible is globally recommended. After molecular and histological examinations, patients with anaplastic astrocytoma, isocitrate dehydrogenase (IDH)-mutant should be primary treated by standard brain radiotherapy and adjuvant temozolomide chemotherapy whereas those with anaplastic astrocytoma, NOS, and anaplastic astrocytoma, IDH-wildtype should be treated following the protocol for glioblastomas. In terms of anaplastic oligodendroglioma, IDH-mutant and 1p19q-codeletion, and anaplastic oligodendroglioma, NOS should be primary treated by standard brain radiotherapy and neoadjuvant or adjuvant PCV (procarbazine, lomustine, and vincristine) combination chemotherapy. CONCLUSION: The KSNO's guideline recommends that WHO grade III cerebral glioma of adults should be treated by maximal safe resection if feasible, followed by radiotherapy and/or chemotherapy according to molecular and histological features of tumors.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Astrocytoma
		                        			;
		                        		
		                        			Brain
		                        			;
		                        		
		                        			Brain Neoplasms
		                        			;
		                        		
		                        			Central Nervous System
		                        			;
		                        		
		                        			Drug Therapy
		                        			;
		                        		
		                        			Drug Therapy, Combination
		                        			;
		                        		
		                        			Glioblastoma
		                        			;
		                        		
		                        			Glioma
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Isocitrate Dehydrogenase
		                        			;
		                        		
		                        			Korea
		                        			;
		                        		
		                        			Lomustine
		                        			;
		                        		
		                        			Oligodendroglioma
		                        			;
		                        		
		                        			Radiotherapy
		                        			;
		                        		
		                        			World Health Organization
		                        			
		                        		
		                        	
4.Korean Clinical Practice Guidelines for Aneurysmal Subarachnoid Hemorrhage
Won Sang CHO ; Jeong Eun KIM ; Sukh Que PARK ; Jun Kyeung KO ; Dae Won KIM ; Jung Cheol PARK ; Je Young YEON ; Seung Young CHUNG ; Joonho CHUNG ; Sung Pil JOO ; Gyojun HWANG ; Deog Young KIM ; Won Hyuk CHANG ; Kyu Sun CHOI ; Sung Ho LEE ; Seung Hun SHEEN ; Hyun Seung KANG ; Byung Moon KIM ; Hee Joon BAE ; Chang Wan OH ; Hyeon Seon PARK ; ; ; ;
Journal of Korean Neurosurgical Society 2018;61(2):127-166
		                        		
		                        			
		                        			Despite advancements in treating ruptured cerebral aneurysms, an aneurysmal subarachnoid hemorrhage (aSAH) is still a grave cerebrovascular disease associated with a high rate of morbidity and mortality. Based on the literature published to date, worldwide academic and governmental committees have developed clinical practice guidelines (CPGs) to propose standards for disease management in order to achieve the best treatment outcomes for aSAHs. In 2013, the Korean Society of Cerebrovascular Surgeons issued a Korean version of the CPGs for aSAHs. The group researched all articles and major foreign CPGs published in English until December 2015 using several search engines. Based on these articles, levels of evidence and grades of recommendations were determined by our society as well as by other related Quality Control Committees from neurointervention, neurology and rehabilitation medicine. The Korean version of the CPGs for aSAHs includes risk factors, diagnosis, initial management, medical and surgical management to prevent rebleeding, management of delayed cerebral ischemia and vasospasm, treatment of hydrocephalus, treatment of medical complications and early rehabilitation. The CPGs are not the absolute standard but are the present reference as the evidence is still incomplete, each environment of clinical practice is different, and there is a high probability of variation in the current recommendations. The CPGs will be useful in the fields of clinical practice and research.
		                        		
		                        		
		                        		
		                        			Aneurysm
		                        			;
		                        		
		                        			Brain Ischemia
		                        			;
		                        		
		                        			Cerebrovascular Disorders
		                        			;
		                        		
		                        			Diagnosis
		                        			;
		                        		
		                        			Disease Management
		                        			;
		                        		
		                        			Hydrocephalus
		                        			;
		                        		
		                        			Intracranial Aneurysm
		                        			;
		                        		
		                        			Mortality
		                        			;
		                        		
		                        			Neurology
		                        			;
		                        		
		                        			Quality Control
		                        			;
		                        		
		                        			Rehabilitation
		                        			;
		                        		
		                        			Risk Factors
		                        			;
		                        		
		                        			Search Engine
		                        			;
		                        		
		                        			Subarachnoid Hemorrhage
		                        			;
		                        		
		                        			Surgeons
		                        			
		                        		
		                        	
5.Hypothermia Inhibits Endothelium-Independent Vascular Contractility via Rho-kinase Inhibition.
Yoon Hee CHUNG ; Keon Woong OH ; Sung Tae KIM ; Eon Sub PARK ; Hyun Dong JE ; Hyuk Jun YOON ; Uy Dong SOHN ; Ji Hoon JEONG ; Hyen Oh LA
Biomolecules & Therapeutics 2018;26(2):139-145
		                        		
		                        			
		                        			The present study was undertaken to investigate the influence of hypothermia on endothelium-independent vascular smooth muscle contractility and to determine the mechanism underlying the relaxation. Denuded aortic rings from male rats were used and isometric contractions were recorded and combined with molecular experiments. Hypothermia significantly inhibited fluoride-, thromboxane A2-, phenylephrine-, and phorbol ester-induced vascular contractions regardless of endothelial nitric oxide synthesis, suggesting that another pathway had a direct effect on vascular smooth muscle. Hypothermia significantly inhibited the fluoride-induced increase in pMYPT1 level and phorbol ester-induced increase in pERK1/2 level, suggesting inhibition of Rho-kinase and MEK activity and subsequent phosphorylation of MYPT1 and ERK1/2. These results suggest that the relaxing effect of moderate hypothermia on agonist-induced vascular contraction regardless of endothelial function involves inhibition of Rho-kinase and MEK activities.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Fluorides
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hypothermia*
		                        			;
		                        		
		                        			Isometric Contraction
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Muscle, Smooth, Vascular
		                        			;
		                        		
		                        			Nitric Oxide
		                        			;
		                        		
		                        			Phosphorylation
		                        			;
		                        		
		                        			Rats
		                        			;
		                        		
		                        			Relaxation
		                        			;
		                        		
		                        			rho-Associated Kinases*
		                        			
		                        		
		                        	
6.Diagnostic Efficacy of the Modified Alvarado Score for Acute Appendicitis in Pregnant Women.
Chul Soo KIM ; Hong In PARK ; Jung Ho LEE ; Woon Hyuk JUNG ; Soo Hyung LEE ; Woo Young NHO ; Seong Hun KIM ; Dong Wook JE ; Michel Sung Pil CHOE ; June Young LEE ; Jin Kun BAE ; Sang Mo JE ; Tae Nyoung CHUNG ; Eui Chung KIM ; Sung Wook CHOI ; Ok Jun KIM
Journal of the Korean Society of Emergency Medicine 2016;27(6):586-594
		                        		
		                        			
		                        			PURPOSE: We aimed to evaluate whether the modified Alvarado score-which is currently being used to diagnose acute appendicitis-can be applicable in the diagnosis of diseases in pregnant women. METHODS: We retrospectively analyzed the medical records of 252 pregnant women who visited our emergency department (ED) with a chief complaint of abdominal pain and a suspicion of acute appendicitis, and ultimately underwent appendix ultrasonography or appendix magnetic resonance imaging (MRI). The modified Alvarado score was calculated for each pregnant woman. A receiver operating characteristic (ROC) curve was drawn for each subject, those in the first trimester, second trimester, and third trimester, from which the best cut-off value, sensitivity and specificity were induced. RESULTS: For all 252 pregnant women who visited our ED, the area under the curve was 0.742 (p<0.001), with sensitivity and specificity of 75.41% and 62.30%, respectively, when using the value of 5 as the cut-off point for the modified Alvarado score. The area under the curve was 0.811 (p<0.001) for those in their first trimester and 0.749 (p<0.001) for those in the second trimester, while it was 0.641, with the p-value of 0.109, for those in the third trimester. CONCLUSION: There is a limitation using the modified Alvarado score alone in pregnant woman, and if there is uncertainty in the diagnosis, other imaging studies, such as appendix ultrasonography or appendix MRI, should be considered.
		                        		
		                        		
		                        		
		                        			Abdominal Pain
		                        			;
		                        		
		                        			Appendicitis*
		                        			;
		                        		
		                        			Appendix
		                        			;
		                        		
		                        			Diagnosis
		                        			;
		                        		
		                        			Emergency Service, Hospital
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Magnetic Resonance Imaging
		                        			;
		                        		
		                        			Medical Records
		                        			;
		                        		
		                        			Pregnancy
		                        			;
		                        		
		                        			Pregnancy Trimester, First
		                        			;
		                        		
		                        			Pregnancy Trimester, Second
		                        			;
		                        		
		                        			Pregnancy Trimester, Third
		                        			;
		                        		
		                        			Pregnant Women*
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			ROC Curve
		                        			;
		                        		
		                        			Sensitivity and Specificity
		                        			;
		                        		
		                        			Ultrasonography
		                        			;
		                        		
		                        			Uncertainty
		                        			
		                        		
		                        	
7.Autologous Platelet-Poor Plasma Gel for Injection Laryngoplasty.
Seung Hoon WOO ; Jin Pyeong KIM ; Jung Je PARK ; Phil Sang CHUNG ; Sang Hyuk LEE ; Han Sin JEONG
Yonsei Medical Journal 2013;54(6):1516-1523
		                        		
		                        			
		                        			PURPOSE: To overcome the potential disadvantages of the use of foreign materials and autologous fat or collagen, we introduce here an autologous plasma gel for injection laryngoplasty. The purpose of this study was to present a new injection material, a plasma gel, and to discuss its clinical effectiveness. MATERIALS AND METHODS: From 2 mL of blood, the platelet poor serum layer was collected and heated at 100degrees C for 12 min to form a plasma gel. The plasma gel was then injected into a targeted site; the safety and efficacy thereof were evaluated in 30 rats. We also conducted a phase I/II clinical study of plasma gel injection laryngoplasty in 11 unilateral vocal fold paralysis patients. RESULTS: The plasma gel was semi-solid and an easily injectable material. Of note, plasma gel maintains the same consistency for up to 1 year in a sealed bottle. However, exposure to room air causes the plasma gel to disappear within 1 month. In our animal study, the autologous plasma gel remained in situ for 6 months in animals with minimal inflammation. Clinical study showed that vocal cord palsy was well compensated for with the plasma gel in all patients at two months after injection with no significant complications. Jitter, shimmer, maximum, maximum phonation time (MPT) and mean voice handicap index (VHI) also improved significantly after plasma gel injection. However, because the injected plasma gel was gradually absorbed, 6 patients needed another injection, while the gel remained in place in 2 patients. CONCLUSION: Injection laryngoplasty with autologous plasma gel may be a useful and safe treatment option for temporary vocal cord palsy.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Aged, 80 and over
		                        			;
		                        		
		                        			Animals
		                        			;
		                        		
		                        			*Blood Platelets
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Laryngoplasty/*methods
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Plasma/*physiology
		                        			;
		                        		
		                        			Rats
		                        			
		                        		
		                        	
8.Sex Determination from the Tibia in Korean Population.
Je Hun LEE ; Seung Ho HAN ; In Hyuk CHUNG
Korean Journal of Physical Anthropology 2010;23(2):61-66
		                        		
		                        			
		                        			There are a number of studies in the world that uses tibia for sex determination, however there are no such studie in Korea. Eight variables were used to determinate sex of tibia. The sample consisted of 170 tibiae (from 55 males and 30 females). The ages for these specimens ranged from 18 and 91 years. Vernier caliper (Absolute Digimetric, Mitutoyo Corp, Japan), osteometric table (Osteometric table, GPM Corp, Swiss) and Ruler (Ruler, Peace Corp, Korea) were used to measure these variables and statistical analysis was performed. Result showed that the accuracy of maximum breadth of lateral articular surface of proximal condyle (LAB) was highest to reached 80.5%; on the contrary, circumference the body that the point found nutrient foramen (CNF) was lowest correlation variable to reach only 68.4%. Other variables except for CNF showed higher than 75.0% accuracy. Equation of sex determining function was made by the stepwise logistic regression using maximum breadth between lateral and medial condyle on the superior aspect (PAB) and maximum length of lateral articular surface of proximal condyle (LAL). The accuracy of the equation showed 84.8%. This study showed that certain parameters of the tibia useful for sex determination in the case of fragment of tibia are found.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Korea
		                        			;
		                        		
		                        			Logistic Models
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Tibia
		                        			
		                        		
		                        	
9.A case of ectopic Cushing's syndrome combined with papillary thyroid carcinoma.
Yong Cheol KIM ; Mun Kyung CHUNG ; Youn Mi SONG ; Hyuk Sang KWON ; Chan Kwon JUNG ; Sung Dae MOON ; Je Ho HAN
Korean Journal of Medicine 2009;76(Suppl 1):S117-S121
		                        		
		                        			
		                        			Locating a corticotropin-releasing hormone (CRH)- or adrenocorticotropic hormone (ACTH)-secreting tumor is challenging. A 69-year-old woman admitted to our hospital for generalized edema was diagnosed with ectopic Cushing's syndrome. We attempted to find an ectopic tumor and could establish no ectopic focus except a retropharyngeal mass in the neck. We diagnosed the retropharyngeal mass as thyroid papillary carcinoma and examined whether the thyroid papillary carcinoma was the ectopic focus. No relationship between thyroid papillary carcinoma and ectopic Cushing's syndrome has been established. We failed to find another ectopic focus, except for the increased uptake of the retropharyngeal mass on fluorodeoxyglucose positron emission tomography (FDG-PET). Ectopic Cushing's syndrome combined with thyroid papillary carcinoma is very rare, so we report this case along with reviews of related literatures.
		                        		
		                        		
		                        		
		                        			Adrenocorticotropic Hormone
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Carcinoma
		                        			;
		                        		
		                        			Carcinoma, Papillary
		                        			;
		                        		
		                        			Corticotropin-Releasing Hormone
		                        			;
		                        		
		                        			Cushing Syndrome
		                        			;
		                        		
		                        			Edema
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Neck
		                        			;
		                        		
		                        			Positron-Emission Tomography
		                        			;
		                        		
		                        			Thyroid Gland
		                        			;
		                        		
		                        			Thyroid Neoplasms
		                        			
		                        		
		                        	
10.Estimation of Maximum Tibia Length from Fragmentary Condition in Korean Populations.
Je Hun LEE ; Seung Ho HAN ; U Young LEE ; Yi Suk KIM ; In Hyuk CHUNG
Korean Journal of Physical Anthropology 2009;22(3):187-193
		                        		
		                        			
		                        			Long limb bones have been used in the derivation of regression equations for stature assessment. Various papers to estimate stature from long limb bones were existed. However fragmentary long bones are found for analyses in forensic cases, it has impossible to derive regression equations for the estimation of stature from the fragments of these bones. In this reason, this study was tried to estimate maximum long bone length specially tibia as measured nine variables. The sample consisted of 170 tibias (55 males and 30 females). The ages for these specimens ranged between 18 and 91 years. Vernier caliper (Mitutoyo, Tokyo, Japan) and osteometric table (GPM, Swiss) were used to measure variable. Statistical analysis was made using SPSS 15.0 for windows to estimate maximum tibia length. The variables, seemed to higher than 0.5 R-square, were circumference the body that the point found nutrient foramen (CNF) in female and maximum breadth between lateral and medial condyle on the superior aspect (PAB), CNF in combined sex. Also, regression equations were made through the stepwise analysis. The R-squares were 0.499 of male, 0.685 of female and 0.617 of combined sex. In the absence of intact long bones, the equations derived from the present study can provide a reliable estimate of maximum tibia length and can estimate stature after all.
		                        		
		                        		
		                        		
		                        			Extremities
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Tibia
		                        			;
		                        		
		                        			Tokyo
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail